News
Hosted on MSN2mon
GKOS Stock Gains Following Positive Study Data on iDose PlatformIn a separate Phase 4 single-arm clinical study involving 60 open-angle glaucoma patients, the iDose TR was implanted during cataract surgery. This combination achieved a remarkable mean IOP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results